|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 215/38 | |
| A61K 31/435 |
| (11) | Patento numeris | 2325171 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11155225.3 |
| Europos patento paraiškos padavimo data | 2006-05-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-05-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-10-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 685460 P | 2005-05-26 | US | |
| 723577 P | 2005-10-04 | US |
| (72) |
Jordan, Thomas A, US
Dowling, John E., US
Chabala, John C., US
|
| (73) |
Aldexa Therapeutics, Inc.,
15 New England Executive Park, Burlington, MA 01803,
US
|
| (54) | Quinoline derivatives for treating retinal diseases |
| Quinoline derivatives for treating retinal diseases |